MedPath
TGA Approval

SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution (311827)

311827

SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution

Janssen-Cilag Pty Ltd

March 9, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/effe1927676a80364ae20240fb6f475b.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/16b3cf744f282c206fa3bfe08dd3bc45.pdf

Active Ingredients

esketamine hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.